SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-079340
Filing Date
2023-07-10
Accepted
2023-07-10 08:04:45
Documents
13
Period of Report
2023-07-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320812d1_8k.htm   iXBRL 8-K 33190
2 EXHIBIT 10.1 tm2320812d1_ex10-1.htm EX-10.1 83007
  Complete submission text file 0001104659-23-079340.txt   310965

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vygr-20230705.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20230705_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20230705_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2320812d1_8k_htm.xml XML 3210
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 231078266
SIC: 2836 Biological Products, (No Diagnostic Substances)